Tag Archives: trial

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema trial

Novartis is aiming its new eye drug Beovu, a challenger to Regeneron’s Eylea, at another of its rival’s key markets. And amid a raft of safety concerns, it’s being very mindful of which data to share. In a phase 3 head-to-head study, Beovu matched Eylea in terms of the best-corrected vision acuity that patients with diabetic… Read More »

Oxford vaccine trial pause isn’t bad news – it’s the process working

By Clare Wilson Michelle D’Urbano The has been great alarm over the news that a trial of a vaccine candidate for the coronavirus, from the University of Oxford and drug firm AstraZeneca, has had to be put on hold after a participant developed strange neurological symptoms. It might seem a cause for concern, but, in… Read More »